Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E van Doorslaer

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
International Journal of Technology Assessment in Health Care|January 1, 1993
Benefits and costs of recombinant human erythropoietin for end-stage renal failure: a review. Benefits and costs of erythropoietinP McNamee, E van Doorslaer, R Segaar
Journal of Medical Virology|December 1, 1994
Cost-effectiveness analysis of vaccination against hepatitis A in travellersE Van Doorslaer, G Tormans, P Van Damme
Vaccine|January 1, 1992
Cost-effectiveness analysis of hepatitis A prevention in travellersG Tormans, P Van Damme, E Van Doorslaer
Health Economics|February 23, 2011
Is there a health penalty of China's rapid urbanization?E Van de Poel, O O'Donnell, E Van Doorslaer
Health Economics|July 24, 2001
Effects of cost sharing on physician utilization under favourable conditions for supplier-induced demandC Van de Voorde, E Van Doorslaer, E Schokkaert
Carbohydrate Research|January 1, 1980
Binding of n-alkyl beta-D-xylopyranosides and n-alkyl 1-thio-beta-D-xylopyranosides to beta-D-xylosidase from Bacillus pumilus PRL B12H Kersters-Hilderson, E Van Doorslaer, C K De Bruyne
Carbohydrate Research|January 15, 1980
Binding of alkyl beta-D-xylopyranosides, containing branched-chain, cyclic, and substituted aglycon groups, to beta-D-xylosidase from Bacillus pumilus PRL B12E Van Doorslaer, H Kersters-Hilderson, C K De Bruyne
Carbohydrate Research|September 1, 1978
beta-D-xylosidase from Bacillus pumilus PRL B12: hydrolysis of aryl beta-D-xylopyranosidesH Kersters-Hilderson, E Van Doorslaer, C K De Bruyne
Vaccine|January 1, 1995
Hepatitis B prevention in Europe: a preliminary economic evaluationP Van Damme, G Tormans, P Beutels, et al.
The Journal of Rheumatology|February 1, 1994
Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trialC Bakker, A Hidding, S van der Linden, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Technology Assessment in Health Care|January 1, 1993
Benefits and costs of recombinant human erythropoietin for end-stage renal failure: a review. Benefits and costs of erythropoietinP McNamee, E van Doorslaer, R Segaar
Journal of Medical Virology|December 1, 1994
Cost-effectiveness analysis of vaccination against hepatitis A in travellersE Van Doorslaer, G Tormans, P Van Damme
Vaccine|January 1, 1992
Cost-effectiveness analysis of hepatitis A prevention in travellersG Tormans, P Van Damme, E Van Doorslaer
Health Economics|February 23, 2011
Is there a health penalty of China's rapid urbanization?E Van de Poel, O O'Donnell, E Van Doorslaer
Health Economics|July 24, 2001
Effects of cost sharing on physician utilization under favourable conditions for supplier-induced demandC Van de Voorde, E Van Doorslaer, E Schokkaert
Carbohydrate Research|January 1, 1980
Binding of n-alkyl beta-D-xylopyranosides and n-alkyl 1-thio-beta-D-xylopyranosides to beta-D-xylosidase from Bacillus pumilus PRL B12H Kersters-Hilderson, E Van Doorslaer, C K De Bruyne
Carbohydrate Research|January 15, 1980
Binding of alkyl beta-D-xylopyranosides, containing branched-chain, cyclic, and substituted aglycon groups, to beta-D-xylosidase from Bacillus pumilus PRL B12E Van Doorslaer, H Kersters-Hilderson, C K De Bruyne
Carbohydrate Research|September 1, 1978
beta-D-xylosidase from Bacillus pumilus PRL B12: hydrolysis of aryl beta-D-xylopyranosidesH Kersters-Hilderson, E Van Doorslaer, C K De Bruyne
Vaccine|January 1, 1995
Hepatitis B prevention in Europe: a preliminary economic evaluationP Van Damme, G Tormans, P Beutels, et al.
The Journal of Rheumatology|February 1, 1994
Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trialC Bakker, A Hidding, S van der Linden, et al.
Pageof 4